Eprontia 25 mg/mL oral solution Images

Generic Name: topiramate

This medication has been identified as Eprontia 25 mg/mL oral solution. It is supplied by Azurity Pharmaceuticals, Inc.

Eprontia is used in the treatment of Migraine Prevention; Lennox-Gastaut Syndrome; Seizure Prevention; Epilepsy; Seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Eprontia 25 mg/mL oral solution is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Eprontia

Generic Name

topiramate

Strength

25 mg/mL oral solution

Availability

Prescription only

Drug Class

Carbonic anhydrase inhibitor anticonvulsants

Pregnancy Category

D - Positive evidence of risk

CSA Schedule

Not a controlled drug

Labeler / Supplier

Azurity Pharmaceuticals, Inc.

National Drug Code (NDC)

52652-9001

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer